The Defense Advanced Research Projects Agency (DARPA) recently awarded the Georgia Tech Research Institute (GTRI) an agreement, as part of their SenSARS program, to develop a sensing platform to detect airborne SARS-CoV-2 particles. Cardea Bio is a sub-contractor to this agreement.
This agreement will enable the two institutions to develop a real-time pathogen identification technology that can be applied to many different defense and civilian environmental monitoring applications.
- Read more about Cardea Bio and the Georgia Tech Research Institute enter DARPA agreement to develop airborne SARS-CoV-2 sensors
Read More | Graphene-Info
Graphene applications, Graphene Sensors, Medicine, Transistors, Technical / Research